Dermagraft-TC: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
WikiModEn2 (talk | contribs) Wikify. |
||
| (10 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
[[Image:Dermagraft.png|right|thumb|]] | [[Image:Dermagraft.png|right|thumb|]] | ||
Dermagraft-TC | '''Dermagraft-TC''' is an artifical [[skin]] created from harvested [[foreskin| foreskins]] from infant [[circumcision]].<ref name='Advanced Biohealing, 2010'>{{REFweb | ||
| quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | |quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | ||
| url=http://www.dermagraft.com/about/overview/ | |url=http://www.dermagraft.com/about/overview/ | ||
| title=Dermagraft-TC: Overview | |title=Dermagraft-TC: Overview | ||
| last= | |last= | ||
| first= | |first= | ||
| publisher=Advanced Biohealing, Inc. | |publisher=Advanced Biohealing, Inc. | ||
| | |website= | ||
| date= | |date= | ||
| accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref> It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb | }}</ref> It is made and sold by [[Advanced Tissue Sciences]] (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb | ||
| quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | |quote=...fibroblast-derived temporary [[skin]] substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | ||
| url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | |url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | ||
| title=Dermagraft-TC | |title=Dermagraft-TC | ||
| last= | |last= | ||
| first= | |first= | ||
| publisher=MediLexicon | |publisher=MediLexicon | ||
| | |website= | ||
| date= | |date= | ||
| accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref><ref name='Transplant News 2007-03-28'>{{REFnews | }}</ref><ref name='Transplant News 2007-03-28'>{{REFnews | ||
| last= | |last= | ||
| first | |first= | ||
|url=http://www.highbeam.com/doc/1G1-47248437.html | |||
| url=http://www.highbeam.com/doc/1G1-47248437.html | |title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA | ||
| title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA | |date=2007-03-28 | ||
| date=2007-03-28 | |publisher=Transplant News | ||
| publisher=Transplant News | |quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary [[skin]] substitute to be approved. | ||
| quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved. | |accessdate=2011-03-06 | ||
| accessdate=2011-03-06 | }}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of [[skin]].<ref>{{REFjournal | ||
}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref> | |last=Daecher | ||
|init=M | |||
|title=Circumcision | |||
|journal=Icon | |||
|date=1998 | |||
|volume=2 | |||
|issue=2 | |||
|pages=70-73 | |||
|url= | |||
|quote= | |||
|pubmedID= | |||
|pubmedCID= | |||
|DOI= | |||
|accessdate= | |||
}}</ref> | |||
{{REF}} | {{REF}} | ||
[[Category:Foreskin | [[Category:Foreskin product]] | ||
[[Category:Financial | [[Category:Financial gain]] | ||
[[Category:From CircLeaks]] | |||
[[Category:From IntactWiki]] | [[Category:From IntactWiki]] | ||
[[de:{{FULLPAGENAME}}]] | |||
Latest revision as of 19:27, 29 October 2022
Dermagraft-TC is an artifical skin created from harvested foreskins from infant circumcision.[1] It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is FDA approved,[2][3] and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.[4]
References
- ↑
Dermagraft-TC: Overview
, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
Quote:Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
- ↑
Dermagraft-TC
, MediLexicon. Retrieved 6 March 2011.
Quote:...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
- ↑
(28 March 2007)."Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA", Transplant News. Retrieved 6 March 2011.
Quote:...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
- ↑
Daecher M. Circumcision. Icon. 1998; 2(2): 70-73.
